Archynetys Live news trend intelligence
◼ Archived Business 🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct

NIKE, Inc. Announces Planned CFO Transition —

Nike has appointed former Pfizer executive David Denton as its new CFO during a period of strategic turnaround.

5sources
6articles
3velocity
+0%since first seen
33d agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📍 How it ended

Nike announced a planned transition for its CFO position. The company named Pfizer executive David Denton as the next CFO.

Epilogue added 19d ago, after coverage quieted.

The brief

NIKE, Inc. has announced a planned transition of its Chief Financial Officer. David Denton, previously an executive at Pfizer, has been named as the successor to the departing CFO.

Coverage from Reuters, Bloomberg, the Wall Street Journal, and WWD emphasizes that this appointment occurs amidst a slow turnaround effort for the company. The official announcement was also confirmed by Nike.

Future developments center on the transition of the CFO role as Denton takes over the position.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 33d ago.

Quick answers

Who is the new CFO of Nike?

David Denton, an executive from Pfizer.

What is the context of this hiring?

According to Reuters, the appointment comes amid a slow turnaround effort.

Which outlets reported the transition?

The news was reported by WWD, Reuters, Bloomberg, the Wall Street Journal, and Nike.

Coverage (6)

Topics

Nike David Denton Pfizer CFO Transition

Related trends